Search results
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 3 days agoOn Monday, Barclays made an adjustment to its outlook on AbbVie (NYSE:ABBV) shares, reducing the...
AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises
Morningstar· 6 days agoBy Dean Seal AbbVie raised its annual adjusted earnings guidance after revenue unexpectedly rose in the first quarter as lower sales of Humira were offset with gains elsewhere ...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Investing.com· 6 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
AbbVie Reports First-Quarter 2024 Financial Results
Benton Courier· 6 days agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
AbbVie: Q1 Earnings Snapshot
Midland Reporter-Telegram· 6 days agoNORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday...
AbbVie’s skin disease drug found to be more effective than Regeneron’s Dupixent in study
WHTC 1450 Holland· 7 days ago(Reuters) - AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition was found to be more effective than Regeneron Pharmaceuticals and ...
AbbVie (ABBV) Could Be a Great Choice
Zacks· 2 days agoCash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 6 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up By Investing.com
Investing.com· 6 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 6 days agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
